US Patent 11236166 CD8 binding agents
All edits
Edits on 8 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Article (+318 characters)
Article
Patent abstract
The present invention relates, in part, to agents that bind CD8 and their use as therapeutic and diagnostic agents. The present invention further relates to pharmaceutical compositions comprising the CD8 binding agents and their use in the treatment of various diseases, including, for example, cancers.
Edits on 15 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Anje Cauwels0
Jan Tavernier0
Nikolai Kley0
Sarah Gerlo0
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
112361660
Date of Patent
February 1, 2022
0Patent Application Number
160753170
Date Filed
February 6, 2017
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Feb, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 11236166 CD8 binding agents
Infobox
Is a
Patent jurisdiction
Patent number
11236166
Date of patent
February 1, 2022
Patent application number
16075317
Date Filed
February 6, 2017
Patent primary examiner
Find more entities like US Patent 11236166 CD8 binding agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
